The CDT Industry Partners

AstraZeneca

AstraZeneca are transforming the future of healthcare by unlocking the power of what science can do for people, society and the planet

Bioarchitech Ltd a biotechnology company based out of the Wood Centre for Innovation in Oxford. 

CDotBio

CDotBio is dedicated to helping sustainable agriculture thrive in the face of climate change. In partnership with RNA developers, biopesticide manufacturers and other biotech innovators, CDotBio are unlocking a revolution in agritech through our unique genetic delivery system technology for crop plants.

Extracellular

The first-choice bioprocessing and scale-up partner for the sustainable bioeconomy. Extracellular provide solutions across bioprocess development, scale-up, media development and cell-line development to companies seeking to create sustainable alternatives to consumer products using biotechnology.

Hoxton Farms

Based in London, Hoxton Farms is creating a deliciously fatty future. We craft cruelty-free, sustainable fats to combine with plant protein for delicious meat alternatives.

Immunocore

Immunocore is a leading T cell receptor (TCR) biotechnology company working to create first-in-class biological therapies to address unmet patient needs in oncology as well as infectious and autoimmune diseases

Lucideon

Lucideon is a materials science consultancy, solving your most complex challenges through materials development, process optimisation, and characterisation

Mewburn Ellis

Mewburn Ellis work with organisations building the brands and technologies that will define tomorrow. Mewburn Ellis can help navigate your business journey, using Intellectual Property to imagine, plan, nurture and protect your innovations and deliver them to market.

Oxford Nanopore

Founded in 2005 as a spin-out from the University of Oxford, Oxford Nanopore  employs more than 600 people from multiple disciplines including nanopore science, molecular biology and applications, informatics, engineering, electronics, manufacturing and commercialisation.

Oxford SimCell Ltd. is a biotechnology company using a novel inactivation method to manufacture genome-free bacterial cells with broad applications in the healthcare sector

Qinetiq

Formed in 2001, QinetiQ manages and operates extensive testing and evaluation capabilities for air, land, sea, and target systems.

Scarlet Therapies

Scarlet Therapeutics is developing a unique platform that generates novel red blood cell-based therapeutics to potentially treat a wide range of diseases. Initially targeted at the rare metabolic diseases, hyperammonaemia and hyperoxaluria, this approach could also be used more broadly to target other metabolic diseases, cancer and autoimmune diseases.